Cyrus Harmon
Gründer bei OLEMA PHARMACEUTICALS, INC.
Vermögen: 9 Mio $ am 30.04.2024
Aktive Positionen von Cyrus Harmon
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| OLEMA PHARMACEUTICALS, INC. | Direktor/Vorstandsmitglied | 07.08.2006 | - |
| Gründer | 07.08.2006 | - | |
| Vorstandsvorsitzender | 01.03.2007 | 01.09.2020 | |
| Technik-/Wissenschafts-/F&E-Leiter | 01.09.2020 | 01.03.2023 | |
| Präsident | 01.03.2007 | 01.09.2020 |
Karriereverlauf von Cyrus Harmon
Ehemalige bekannte Positionen von Cyrus Harmon
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| AFFYMETRIX, INC. | Corporate Officer/Principal | 01.01.2000 | 01.01.2002 |
Neomorphics, Inc.
 Neomorphics, Inc. Medical SpecialtiesHealth Technology Neomorphics, Inc. develops, analyzes, and manages genetic information to improve disease. The company is based in Berkeley, CA. The company was founded by Cyrus L. Harmon, Martin G. Reese. Neomorphics was acquired by Affymetrix, Inc., part of Thermo Fisher Scientific, Inc. from April 01, 2016 on October 31, 2000 for $85.92 million. | Vorstandsvorsitzender | 01.01.1996 | 01.01.2000 |
| Gründer | 01.01.1996 | 01.01.2000 |
Ausbildung von Cyrus Harmon
| University of California, Berkeley | Doctorate Degree |
Statistik
International
| Vereinigte Staaten | 5 |
Operativ
| Chief Executive Officer | 2 |
| Founder | 2 |
| Director/Board Member | 1 |
Sektoral
| Health Technology | 4 |
| Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| OLEMA PHARMACEUTICALS, INC. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Affymetrix, Inc.
 Affymetrix, Inc. Medical SpecialtiesHealth Technology Affymetrix, Inc. develops, manufactures and sells products and services for genetic analysis. The company was founded by Stephen P. A. Fodor in 1992 and is headquartered in Santa Clara, CA. | Health Technology |
Neomorphics, Inc.
Neomorphics, Inc. Medical SpecialtiesHealth Technology Neomorphics, Inc. develops, analyzes, and manages genetic information to improve disease. The company is based in Berkeley, CA. The company was founded by Cyrus L. Harmon, Martin G. Reese. Neomorphics was acquired by Affymetrix, Inc., part of Thermo Fisher Scientific, Inc. from April 01, 2016 on October 31, 2000 for $85.92 million. | Health Technology |
- Börse
- Insiders
- Cyrus Harmon
- Erfahrung
